Akebia Therapeutics dba Keryx Biopharmaceutials, Inc recalls Auryxia (ferric citrate) tablets, 210 mg*, 200 tablets bottle, RX ONLY, Manufactured for and distributed by: KERYX BIOPH
Recalled February 24, 2021 · FDA recall D-0260-2021 · Akebia Therapeutics
Hazard
Failed Dissolution Specifications · FDA Class III
Units
17,664 bottles
Sold at
Nationwide.
Description
Failed Dissolution Specifications
Product
Auryxia (ferric citrate) tablets, 210 mg*, 200 tablets bottle, RX ONLY, Manufactured for and distributed by: KERYX BIOPHARMACEUTICALS, INC., 245 First Street, Suite 1400, Cambridge, MA 02142, USA, NDC 59922-0631-01.
Manufacturer(s)
Akebia Therapeutics dba Keryx Biopharmaceutials, Inc
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →